Multiomics

Virtual event

Multiomics – The medicine of tomorrow at your fingertips

February 25, 2025 | 04:00 – 05:30 pm CET
Virtual event on ZOOM

Omic technologies have matured over the last 20 years to provide broad and robust pictures of a person’s biology. Combined with an appropriate study design, omic layers can be integrated to reveal mechanisms and complex biomarkers that will enable a new generation of care. While genomics is beginning to make its place in medical practice, other omics such as metabolomics are still at the threshold of their implementation into routine diagnostic and prognostic procedures. Multiomics data analysis is possibly the most powerful way to make use of omics, from personalized medicine to population health.

In this virtual event, our three speakers will discuss how omics are leveraged in today’s biomedical research, and the added value of including metabolomics in a multiomics approach.

Program overview

Speakers

Ass. Prof. Spencer Rosario

Assistant Professor of Oncology
Roswell Park Comprehensive Cancer
New York | United States

Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer

Abstract will follow soon

Alice Limonciel, Ph.D.

CSO
biocrates life sciences ag | Austria

Multiomics for 5P medicine

Metabolomics technologies have matured over the last 20 years to provide broad and robust pictures of a person’s biology. Combined with an appropriate study design, metabolomics can reveal mechanisms and complex biomarkers that will enable a new generation of care. Thanks to the development of standardized metabolomics, the implementation of this tool in routine diagnostic and prognostic procedures is at our fingertips. Metabolomics also integrates very well with other omics (genomics, epigenomics, proteomics, microbiome…) in multiomics data analysis, providing powerful tools for personalized medicine and population health applications. In this talk, Dr. Alice Limonciel, the chief scientific officer of biocrates, will discuss how metabolomics is leveraged in today’s biomedical research, and the added value of including metabolomics in a multiomics approach.

Juozas Gordevicius, Ph.D.

Founder, Scientist and CTO
Vugene | Lithuania

Tbd